Mastodawn

A highly effective clinical protocol that combines the #immunotherapy atezolizumab (Tecentriq®) with standard adjuvant FOLFOX chemotherapy to treat patients with resected stage III #colon #cancer exhibiting deficient DNA mismatch repair (dMMR).
#Oncology #Immunology #sflorg
https://www.sflorg.com/2026/03/ongy03272601.html

Immunotherapy significantly improves outcomes for colon cancer

Results from the pivotal Phase III Alliance ATOMIC A021502 trial

Scientific Frontline 1d ago

Chronic intestinal inflammation leaves lasting molecular scars, or epigenetic "memories," on seemingly healed gut tissues, fundamentally priming these healthy-appearing cells for future cancer development.
#Epigenetics #Oncology #Genomics #Gastroenterology #sflorg
https://www.sflorg.com/2026/03/ongy03262602.html

How inflammation may prime the gut for cancer

The epigenetic memory is part of a “one-two punch” that, along with a cancer-promoting mutation, can accelerate tumor growth

Scientific Frontline 1d ago

The thymus gland, historically categorized as a predominantly active organ during childhood, remains a vital biological regulator in adulthood, with its health directly correlating to longevity, disease resistance, and immune stability.
#Immunology #Radiology #Oncology #Gerontology #sflorg
https://www.sflorg.com/2026/03/imgy03262601.html

The underestimated thymus: New studies reveal its relevance for healthy aging

People with a healthy thymus gland live longer and are less likely to fall ill

Jack C.M 1d ago

I was asked if there was an ‘everything’ test for cancer. Despite bold claims, no such thing exists | Via @guardian #Health ❤️‍🩹 🧑‍⚕️ #MedicalScience 💉💊🏥🩸😷 #Oncology

I was asked if there was an ‘e...

I was asked if there was an ‘everything’ test for cancer. Despite bold claims, no such thing exists

For oncologists like me, it would be a different world if we could accurately detect cancer before it metastasised and reassure patients that early intervention saved lives

The Guardian

Scientific Frontline 1d ago

Stromal cells function as the "architects" of lymph nodes by directing immune cells via chemical signals, but during the development of B cell lymphomas, inflammatory feedback loops reprogram these cells, actively destroying the lymph node's structural organization.
#Oncology #Immunology #Hematology #sflorg
https://www.sflorg.com/2026/03/ongy03262601.html

The influence of lymph node architecture on lymphoma

Lymph nodes are key control centers in the immune system and play an important role in defending the body against infections and tumors

Industry Examiner 1d ago

Merck’s $6.7B Terns buy is less about leukemia than life after Keytruda.

When one drug drives nearly half of revenue, M&A becomes a way to buy time before the patent cliff.

Read:
https://biotech.industryexaminer.com/merck-terns-deal-keytruda-patent-cliff-biotech-m-and-a/

#Biotech #Pharma #Merck #Oncology #PatentCliff #BiotechM&A #TechNews #BioTechne

Merck’s $6.7 billion Terns deal is really a bet on life after Keytruda - Biotech Industry Examiner

The target is a leukemia drug developer. The real objective is something larger: time, diversification, and a more believable post-Keytruda growth story.

Biotech Industry Examiner

Scientific Frontline 1d ago

Cuproptosis is a specific form of cell death triggered by an excess of intracellular copper. Utilizing this mechanism, researchers have developed a light-activated, copper-based agent complex embedded in polymeric nanoparticles that selectively targets and destroys cancer cells while preserving healthy tissue.
#MedicalInorganicChemistry #Oncology #Nanobiotechnology #Photopharmacology #sflorg
https://www.sflorg.com/2026/03/phar03262601.html

Copper Overload Kills Cancer Cells

A copper-based agent complex kills cancer cells in a novel way.

Aniket 1d ago

𝗪𝗵𝘆 𝗶𝘀 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗱𝗼𝗺𝗶𝗻𝗮𝘁𝗶𝗻𝗴 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗱𝗲𝗺𝗮𝗻𝗱?
Rising cancer cases, 𝘄𝗶𝘁𝗵 ~𝟴.𝟳 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗰𝗮𝘀𝗲𝘀 𝗶𝗻 𝗔𝗣𝗔𝗖, are driving strong demand for targeted biologic therapies and monoclonal antibodies.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://www.kenresearch.com/industry-reports/asia-pacific-biopharmaceuticals-market?utm_source=Mastadon&utm_medium=Social&utm_campaign=Aniket

#Oncology #CancerCare #Biotech #HealthcareTrends